|Day Low/High||5.86 / 6.49|
|52 Wk Low/High||2.93 / 18.10|
Joint venture partner Emerald Health appears to be struggling.
China trade issue is no longer dominating the action.
I thought the sector might have been bottoming out, but it's not.
This group appears oversold and downgrades of the big cannabis names may trigger a "buy the bad news" reaction.
I'm not disappointed that Village Farms is raising money. I'm disappointed in how it transpired.
There are some stock moves that will simply go without explanation. Ever.
If you see something you love, then take a nibble, but big bites aren't on the menu for me today.
Let's check out the charts and indicators to see if they are growing fast too.
A host of other cannabis-related stocks has sprouted up that appear better for investing.
So many stocks, so much news, so little time. The good news is I'm letting you borrow my shovel.
The business continues to churn forward as the company announced it has achieved a full run-rate production of 75K kg at its Delta 3 greenhouse.
CEO MIke DeGiglio on the company's long history as a greenhouse grower, its biggest opportunities, Canadian joint venture Pure Sunfarms, and its footprint in one the best growing climates in the U.S. for cannabis.
It all comes down to matching my time frame.
For aggressive investors seeking to broaden their exposure in the cannabis and CBD space, I view VFF as an opportunity.
Five top marijuana stocks and four CBD plays in this speculative space.
The fact that everyone wants to know everyone's thoughts about Canopy Growth should tell you everything you want to know about CGC's current valuation and ownership. In fact, the Canadian LPs (Licensed Producers) are a tough game right now. These ar...
Recently uplisted CTST is a huge player in the medical marijuana market.
I wouldn't initiate a new, full position today, but I would initiate a partial position in case this small float name runs away before we see a pullback.